AU Patent

AU355056S — Respiratory apparatus

Assigned to Teva UK Ltd · Expires 2014-04-16 · 12y expired

What this patent protects

Newness and distinctiveness resides in the visual features including shape and configuration of a RESPIRATORY APPARATUS including a transparent/translucent cap as shown in the accompanying drawings.

USPTO Abstract

Newness and distinctiveness resides in the visual features including shape and configuration of a RESPIRATORY APPARATUS including a transparent/translucent cap as shown in the accompanying drawings.

Drugs covered by this patent

beclomethasone-dipropionate (BECLOMETHASONE DIPROPIONATE)

Patent Metadata

Patent number: AU355056S
Jurisdiction: AU
Classification: —
Expires: 2014-04-16
Drug substance claim: No
Drug product claim: No
Assignee: Teva UK Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.